Postoperative Radiation Therapy (PORT) Might Improve Overall Survival (OS) In Patients
The past Results of researchers who had shown postoperative radiation therapy (PORT) for patients...
Read More
Hematology/Oncology
SCLC Patients Subgroup With Short Survival
Although chemotherapy and radiation therapy are effective against small cell lung cancer (SCLC),...
Read More
cfDNA Increased in Patients With Pulmonary Arterial Hypertension
FRIDAY, Sept. 16, 2022 (HealthDay News) — Patients with pulmonary arterial hypertension...
Read More
Physician Burnout May Raise Risk for Patient Safety Events
FRIDAY, Sept. 16, 2022 (HealthDay News) — Burnout in physicians is associated with a...
Read More
T-Cell Redirection Therapy Studied for Relapsed Multiple Myeloma
THURSDAY, Sept. 15, 2022 (HealthDay News) — In patients with heavily pretreated...
Read More
Severity of Sleep Apnea and Related Hypoxia Tied to Cancer
THURSDAY, Sept. 15, 2022 (HealthDay News) — Oxygen deprivation resulting from obstructive...
Read More
FDG-PET May Predict Response to Neoadjuvant Therapy in Pancreatic Cancer
THURSDAY, Sept. 15, 2022 (HealthDay News) — For patients with borderline resectable/locally...
Read More
Cesarean Section Tied to Higher Risk for Later Leukemia in Offspring
THURSDAY, Sept. 15, 2022 (HealthDay News) — Elective cesarean section (CS) is associated...
Read More
Neoadjuvant Pembrolizumab Not Tied to More AEs in Oral Cavity SCC
THURSDAY, Sept. 15, 2022 (HealthDay News) — Among patients with local regionally advanced...
Read More
Hypofractionated Proton Therapy for Prostate and Pelvic Lymph Nodes in Phase II
For a study, researchers sought to report acute changes in patient-reported quality of life...
Read More
Metastatic Castration-Resistant Prostate Cancer: Predictive Model for Overall Survival
Prognostic models for patients with metastatic castration-resistant prostate cancer (mCRPC) that...
Read More
Disparities in Prostate Cancer Health May Be Caused by Racial Differences in Mitochondrial-Derived Peptides
Small open reading frames (sORF) in the mitochondrial genome generate quantifiable...
Read More
Study the Failure of Benign Prostatic Hyperplasia (BPH)/Lower Urinary Tract Symptoms (LUTS)
Researchers still don’t fully understand how lower urinary tract symptoms (LUTS) and benign...
Read More
Prostate Cancer Patient Lymph Node Staging Optimization
There were currently no established standards for quantitatively assessing 68Ga-PSMA-PET/CT...
Read More
P35-1 ED in Metastatic PC Patients Treated with ADT
Treatment for both localized and metastatic prostate cancer (PC) affects sexual function. In...
Read More
MO24-6 mHSPC Incidence, Mortality, and Clinical Characteristics
The incidence and fatality rates for prostate cancer vary substantially between Asians and...
Read More
MO20-3 CAPE: Enzalutamide or Abiraterone Drug Resistance in PCa Cells
In order to treat metastatic castration-resistant prostate cancer (mCRPC), 2 medications that...
Read More
26P Uterine Sarcoma: A Retrospective Study
Less than 3% of gynecologic malignancies and 3 to 7% of uterine malignancies are uterine sarcomas...
Read More
High-Grade B-Cell Lymphoma, NOS, Diagnosis and Treatment
A recently developed diagnostic category for aggressive B-cell lymphomas is high-grade B-cell...
Read More
The Use of Sutimlimab in Cold Agglutinin Disease Patients
Sutimlimab, a first-in-class humanized immunoglobulin G4 (IgG4) monoclonal antibody, quickly...
Read More